Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma

Brian P. Buckingham, Denise M. Inman, Wendi Lambert, Ericka Oglesby, David J. Calkins, Michael R. Steele, Monica L. Vetter, Nicholas Marsh-Armstrong, Philip J. Horner

Research output: Contribution to journalArticle

Abstract

Glaucoma is characterized by retinal ganglion cell (RGC) pathology and a progressive loss of vision. Previous studies suggest RGC death is responsible for vision loss in glaucoma, yet evidence from other neurodegenerative diseases suggests axonal degeneration, in the absence of neuronal loss, can significantly affect neuronal function. To characterize RGC degeneration in the DBA/2 mouse model of glaucoma, we quantified RGCs in mice of various ages using neuronal-specific nuclear protein (NeuN) immunolabeling, retrograde labeling, and optic nerve axon counts. Surprisingly, the number of NeuN-labeled RGCs did not decline significantly until 18 months of age, at which time a significant decrease in RGC somal size was also observed. Axon dysfunction and degeneration occurred before loss of NeuN-positive RGCs, because significant declines in RGC number assayed by retrograde tracers and axon counts were observed at 13 months. To examine whether axonal dysfunction/degeneration affected gene expression in RGC axons or somas, NeuN and neurofilament-heavy (NF-H) immunolabeling was performed along with quantitative reverse transcription-PCR for RGC-specific genes in retinas of aged DBA/2 mice. Although these mice had similar numbers of NeuN-positive RGCs, the expression of neurofilament light, Brn-3b, and Sncg mRNA varied; this variation in RGC-specific gene expression was correlated with the appearance of NF-H immunoreactive RGC axons. Together, these data support a progression of RGC degeneration in this model of glaucoma, beginning with loss of retrograde label, where axon dysfunction and degeneration precede neuronal loss. This progression of degeneration suggests a need to examine the RGC axon as a locus of pathology in glaucoma.

Original languageEnglish (US)
Pages (from-to)2735-2744
Number of pages10
JournalJournal of Neuroscience
Volume28
Issue number11
DOIs
StatePublished - Mar 12 2008

Fingerprint

Retinal Ganglion Cells
Ganglia
Glaucoma
Axons
Nuclear Proteins
Intermediate Filaments
Inbred DBA Mouse
Pathology
Gene Expression
Carisoprodol
Optic Nerve
Cell Size
Neurodegenerative Diseases
Reverse Transcription
Retina
Cell Death
Cell Count
Light

Keywords

  • Axon
  • Death
  • Degeneration
  • Optic nerve
  • RGC

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Buckingham, B. P., Inman, D. M., Lambert, W., Oglesby, E., Calkins, D. J., Steele, M. R., ... Horner, P. J. (2008). Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. Journal of Neuroscience, 28(11), 2735-2744. https://doi.org/10.1523/JNEUROSCI.4443-07.2008

Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. / Buckingham, Brian P.; Inman, Denise M.; Lambert, Wendi; Oglesby, Ericka; Calkins, David J.; Steele, Michael R.; Vetter, Monica L.; Marsh-Armstrong, Nicholas; Horner, Philip J.

In: Journal of Neuroscience, Vol. 28, No. 11, 12.03.2008, p. 2735-2744.

Research output: Contribution to journalArticle

Buckingham, BP, Inman, DM, Lambert, W, Oglesby, E, Calkins, DJ, Steele, MR, Vetter, ML, Marsh-Armstrong, N & Horner, PJ 2008, 'Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma', Journal of Neuroscience, vol. 28, no. 11, pp. 2735-2744. https://doi.org/10.1523/JNEUROSCI.4443-07.2008
Buckingham BP, Inman DM, Lambert W, Oglesby E, Calkins DJ, Steele MR et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. Journal of Neuroscience. 2008 Mar 12;28(11):2735-2744. https://doi.org/10.1523/JNEUROSCI.4443-07.2008
Buckingham, Brian P. ; Inman, Denise M. ; Lambert, Wendi ; Oglesby, Ericka ; Calkins, David J. ; Steele, Michael R. ; Vetter, Monica L. ; Marsh-Armstrong, Nicholas ; Horner, Philip J. / Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. In: Journal of Neuroscience. 2008 ; Vol. 28, No. 11. pp. 2735-2744.
@article{19e0a45d44fa420fbfaee4e8da1c799d,
title = "Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma",
abstract = "Glaucoma is characterized by retinal ganglion cell (RGC) pathology and a progressive loss of vision. Previous studies suggest RGC death is responsible for vision loss in glaucoma, yet evidence from other neurodegenerative diseases suggests axonal degeneration, in the absence of neuronal loss, can significantly affect neuronal function. To characterize RGC degeneration in the DBA/2 mouse model of glaucoma, we quantified RGCs in mice of various ages using neuronal-specific nuclear protein (NeuN) immunolabeling, retrograde labeling, and optic nerve axon counts. Surprisingly, the number of NeuN-labeled RGCs did not decline significantly until 18 months of age, at which time a significant decrease in RGC somal size was also observed. Axon dysfunction and degeneration occurred before loss of NeuN-positive RGCs, because significant declines in RGC number assayed by retrograde tracers and axon counts were observed at 13 months. To examine whether axonal dysfunction/degeneration affected gene expression in RGC axons or somas, NeuN and neurofilament-heavy (NF-H) immunolabeling was performed along with quantitative reverse transcription-PCR for RGC-specific genes in retinas of aged DBA/2 mice. Although these mice had similar numbers of NeuN-positive RGCs, the expression of neurofilament light, Brn-3b, and Sncg mRNA varied; this variation in RGC-specific gene expression was correlated with the appearance of NF-H immunoreactive RGC axons. Together, these data support a progression of RGC degeneration in this model of glaucoma, beginning with loss of retrograde label, where axon dysfunction and degeneration precede neuronal loss. This progression of degeneration suggests a need to examine the RGC axon as a locus of pathology in glaucoma.",
keywords = "Axon, Death, Degeneration, Optic nerve, RGC",
author = "Buckingham, {Brian P.} and Inman, {Denise M.} and Wendi Lambert and Ericka Oglesby and Calkins, {David J.} and Steele, {Michael R.} and Vetter, {Monica L.} and Nicholas Marsh-Armstrong and Horner, {Philip J.}",
year = "2008",
month = "3",
day = "12",
doi = "10.1523/JNEUROSCI.4443-07.2008",
language = "English (US)",
volume = "28",
pages = "2735--2744",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "11",

}

TY - JOUR

T1 - Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma

AU - Buckingham, Brian P.

AU - Inman, Denise M.

AU - Lambert, Wendi

AU - Oglesby, Ericka

AU - Calkins, David J.

AU - Steele, Michael R.

AU - Vetter, Monica L.

AU - Marsh-Armstrong, Nicholas

AU - Horner, Philip J.

PY - 2008/3/12

Y1 - 2008/3/12

N2 - Glaucoma is characterized by retinal ganglion cell (RGC) pathology and a progressive loss of vision. Previous studies suggest RGC death is responsible for vision loss in glaucoma, yet evidence from other neurodegenerative diseases suggests axonal degeneration, in the absence of neuronal loss, can significantly affect neuronal function. To characterize RGC degeneration in the DBA/2 mouse model of glaucoma, we quantified RGCs in mice of various ages using neuronal-specific nuclear protein (NeuN) immunolabeling, retrograde labeling, and optic nerve axon counts. Surprisingly, the number of NeuN-labeled RGCs did not decline significantly until 18 months of age, at which time a significant decrease in RGC somal size was also observed. Axon dysfunction and degeneration occurred before loss of NeuN-positive RGCs, because significant declines in RGC number assayed by retrograde tracers and axon counts were observed at 13 months. To examine whether axonal dysfunction/degeneration affected gene expression in RGC axons or somas, NeuN and neurofilament-heavy (NF-H) immunolabeling was performed along with quantitative reverse transcription-PCR for RGC-specific genes in retinas of aged DBA/2 mice. Although these mice had similar numbers of NeuN-positive RGCs, the expression of neurofilament light, Brn-3b, and Sncg mRNA varied; this variation in RGC-specific gene expression was correlated with the appearance of NF-H immunoreactive RGC axons. Together, these data support a progression of RGC degeneration in this model of glaucoma, beginning with loss of retrograde label, where axon dysfunction and degeneration precede neuronal loss. This progression of degeneration suggests a need to examine the RGC axon as a locus of pathology in glaucoma.

AB - Glaucoma is characterized by retinal ganglion cell (RGC) pathology and a progressive loss of vision. Previous studies suggest RGC death is responsible for vision loss in glaucoma, yet evidence from other neurodegenerative diseases suggests axonal degeneration, in the absence of neuronal loss, can significantly affect neuronal function. To characterize RGC degeneration in the DBA/2 mouse model of glaucoma, we quantified RGCs in mice of various ages using neuronal-specific nuclear protein (NeuN) immunolabeling, retrograde labeling, and optic nerve axon counts. Surprisingly, the number of NeuN-labeled RGCs did not decline significantly until 18 months of age, at which time a significant decrease in RGC somal size was also observed. Axon dysfunction and degeneration occurred before loss of NeuN-positive RGCs, because significant declines in RGC number assayed by retrograde tracers and axon counts were observed at 13 months. To examine whether axonal dysfunction/degeneration affected gene expression in RGC axons or somas, NeuN and neurofilament-heavy (NF-H) immunolabeling was performed along with quantitative reverse transcription-PCR for RGC-specific genes in retinas of aged DBA/2 mice. Although these mice had similar numbers of NeuN-positive RGCs, the expression of neurofilament light, Brn-3b, and Sncg mRNA varied; this variation in RGC-specific gene expression was correlated with the appearance of NF-H immunoreactive RGC axons. Together, these data support a progression of RGC degeneration in this model of glaucoma, beginning with loss of retrograde label, where axon dysfunction and degeneration precede neuronal loss. This progression of degeneration suggests a need to examine the RGC axon as a locus of pathology in glaucoma.

KW - Axon

KW - Death

KW - Degeneration

KW - Optic nerve

KW - RGC

UR - http://www.scopus.com/inward/record.url?scp=40849088250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849088250&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.4443-07.2008

DO - 10.1523/JNEUROSCI.4443-07.2008

M3 - Article

C2 - 18337403

AN - SCOPUS:40849088250

VL - 28

SP - 2735

EP - 2744

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 11

ER -